PP244—Therapeutic and supra-therapeutic intravenous doses of mavoglurant (AFQ056) do not prolong the QTc interval in healthy subjects
Ufer, M., Tisserant, A., Dodman, A., Voltz, E., Salunke, A., Woessner, R., Sagkriotis, A., Jordaan, P., Legangneux, E.Volume:
35
Language:
english
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2013.07.281
Date:
August, 2013
File:
PDF, 71 KB
english, 2013